Professional Advisory Board

Professional advisors to the Children’s Cause for Cancer Advocacy (CCCA) are among the nation’s most distinguished researchers in pediatric oncology. They offer keen insights pro bono to CCCA on issues of national importance in the research, care, treatment, and follow-up of children with cancer and long-term survivors.

Chairman

• David G. Poplack, MD Elise C. Young Professor of Pediatric Oncology Head, Hematology Oncology Section, Department of Pediatrics, Baylor College of Medicine Deputy Director, Dan L. Duncan Cancer Center, Baylor College of Medicine

Members

• Robert J. Arceci, MD, PhD Department of Pediatric OncologyThe Sidney Kimmel Comprehensive Cancer Center
  Johns Hopkins Hospital, Baltimore, MD
• Archie Bleyer, MD Medical Advisor to the Cancer Treatment Center at St. Charles Medical Center, Bend, OR
• Clinical Research Professor at Oregon Health & Sciences University in Portland
• Mark Bernstein, MD Chief of Hematology/Oncology Department
  Saint Justine Hospital, Montreal, Quebec, Canada
• Robert P. Castleberry, MD Professor of Pediatrics, Pediatric Hematology/Oncology
  University of Alabama at Birmingham, Birmingham, AL
• Henry Friedman, MD Deputy Director of the Preston Robert Tisch Brain Tumor Center at Duke University Medical Center, Durham, NC
• Daniel M. Green, MD Professor of Pediatric Oncology at Roswell Park Cancer Institute, Buffalo, NY
• Michael P. Link, MD Professor of Pediatric Hematology/Oncology at Stanford University School of Medicine
  
• Director of the Bass Center for Cancer and Blood Diseases at the Lucile Salter Packard Children's Hospital at Stanford
• President-Elect of ASCO (2011-2012 Term)
• Sharon Murphy, MD Inaugural Director of the Greehey Children’s Cancer Research Institute and Professor of Pediatrics
  University of Texas Health Science Center, San Antonio, TX (2002-2008)
• Scholar-in-residence at the Institute of Medicine (IOM) in Washington, D.C.
• Gregory H. Reaman, MD Chairman of the Children’s Oncology Group, Bethesda, MD
• Pediatric Oncologist at Children's National in Washington, D.C.
• Charles A. Sklar, MD Director, Long Term Follow-Up Program
  Memorial Sloan-Kettering Cancer Center, New York, NY

Institutional affiliation noted for purposes of identification only.